Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modification of MYD88 splicing using modified oligonucleotides

Modification of MYD88 splicing using modified oligonucleotides

US Patent 8765703 · Granted Jul 1, 2014

Estimated economic value: $58,508,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for modulation of LMNA expression2018
Antisense oligonucleotides directed against connective tissue growth factor and 2017
Regulation of epigenetic control of gene expression2017
Method of treating keloids or hypertrophic scars using antisense compounds targe2015
Chimeric oligomeric compounds for modulation of splicing2015
Antisense oligonucleotides directed against connective tissue growth factor and 2015
Method for reducing scarring during wound healing using antisense compounds dire2015
Method of inhibiting miR-33 using a modified oligonucleotide2014
Methods for inhibiting expression of connective tissue growth factor2014
Chimeric oligomeric compounds for modulation of splicing2013
Methods of determining potency of chemically-synthesized oligonucleotides2012
Antisense oligonucleotides directed against connective tissue growth factor and 2012